Recruiting Heart Attack Studies in Great Neck
A Phase 2a Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
The main objective is to assess the safety and tolerability of inebilizumab in adult participants with active and refractory systemic lupus erythematosus (SLE) with nephritis (Subprotocol A) and to as...
KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis
A Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy for Subjects with Systemic Sclerosis...
About Heart Attack Clinical Trials in Great Neck
A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.
There are currently 2 heart attack clinical trials recruiting participants in Great Neck, NEW%20YORK. These studies are seeking a combined 119 participants. Research is being sponsored by Amgen, Kyverna Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Attack Clinical Trials in Great Neck — FAQ
Are there heart attack clinical trials in Great Neck?
Yes, there are 2 heart attack clinical trials currently recruiting in Great Neck, NEW%20YORK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Great Neck?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Great Neck research site will contact you about next steps.
Are clinical trials in Great Neck free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Great Neck studies also compensate for your time and travel.
What heart attack treatments are being tested?
The 2 active trials in Great Neck are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.
Data updated March 2, 2026 from ClinicalTrials.gov